Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Michal Pesta

Czech Republic
Publications

Comprehensive Statistical Analysis of the Pharmacokinetics, Safety and Clinical Benefit Rate of Mitotam in a Single-Center Phase I/Ib Trial in Patients with Metastatic Solid Tumors

Background: Mitochondrially Targeted Tamoxifen (MitoTam), the first mitochondrial inhibitor to disrupt Complex I (CI)-dependent respiration, previously showed antitumor activity against Renal Cell Carcinoma (RCC) with a good safety profile. We investigated the relationships of Pharmacokinetic (PK) parameters, biodistribution and patient baseline di... Read More»

Olga Bartosova, Zuzana Bielcikova, Jan Stursa, Michal Pesta, Jiri Neuzil, Miroslava Bursova, Ondrej Slanar, Irena Stenglova Netikova and Lukas Werner

: Diagnos Pathol Open

10.4172/2476-2024.1000237

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top